Skip to main content

and
  1. No Access

    Article

    Factors associated with the melanoma diagnostic interval in Ontario, Canada: a population-based study

    Protracted times to diagnosis of cancer can lead to increased patient anxiety, and in some cases, disease progression and worse outcomes. This study assessed the time to diagnosis for melanoma, and its variabi...

    Meaghan E. Mavor, Timothy P. Hanna, Yuka Asai, Hugh Langley in British Journal of Cancer (2024)

  2. Article

    Open Access

    A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada

    Health technology assessment (HTA) can be used to make healthcare systems more equitable and efficient. Advances in precision oncology are challenging conventional thinking about HTA. Precision oncology advanc...

    Dean A. Regier, Samantha Pollard, Melanie McPhail, Tania Bubela in npj Precision Oncology (2022)

  3. Article

    Open Access

    A population-based validation study of the 8th edition UICC/AJCC TNM staging system for cutaneous melanoma

    The 8th edition UICC/AJCC TNM8 (Tumour, Nodes, Metastasis) melanoma staging system introduced several modifications from the 7th edition (TNM7), resulting in changes in survival and subgroup composition. We set o...

    Matthew C. Hynes, Paul Nguyen, Patti A. Groome, Yuka Asai, Meaghan E. Mavor in BMC Cancer (2022)

  4. Article

    Open Access

    Cancer staging in individuals with a severe psychiatric illness: a cross-sectional study using population-based cancer registry data

    Advanced cancer stage at diagnosis may explain high cancer mortality among patients with a severe psychiatric illness (SPI). Studies to date investigating advanced stage cancer at diagnosis as a potential expl...

    Alyson L. Mahar, Paul Kurdyak, Timothy P. Hanna, Natalie G. Coburn in BMC Cancer (2020)

  5. Article

    Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic

    During the COVID-19 global pandemic, the cancer community faces many difficult questions. We will first discuss safety considerations for patients with cancer requiring treatment in SARS-CoV-2 endemic areas. W...

    Timothy P. Hanna, Gerald A. Evans, Christopher M. Booth in Nature Reviews Clinical Oncology (2020)

  6. Article

    Open Access

    Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada

    For novel cancer treatments, effectiveness in clinical practice is not always aligned with clinical efficacy results. As such it is important to understand a treatment’s real-world effectiveness. We examined r...

    Wei Fang Dai, Jaclyn M. Beca, Ruth Croxford, Wanrudee Isaranawatchai in BMC Cancer (2020)

  7. Article

    Open Access

    Cancer control in develo** countries: using health data and health services research to measure and improve access, quality and efficiency

    Cancer is a rapidly increasing problem in develo** countries. Access, quality and efficiency of cancer services in develo** countries must be understood to advance effective cancer control programs. Health...

    Timothy P Hanna, Alfred CT Kangolle in BMC International Health and Human Rights (2010)